[ad_1] Drug major Dr Reddy’s Laboratories Ltd on Tuesday (February 25) said the United States Food and Drug Administration (USFDA) found some issues at its active pharmaceutical ingredient (API) manufacturing facility (CTO-2) in Bollaram, Hyderabad, and asked it to sort them out. “Further to our intimation dated November 19, 2024, on the inspection conducted by the […]
Kazakhstan fines Dr Reddy’s subsidiary ₹28.7 lakh for discontinuing some expense claims – CNBC TV18
[ad_1] Drug firm Dr Reddy’s Laboratories Ltd on Thursday (December 5) announced that its step-down wholly owned subsidiary, Dr Reddy’s Laboratories Kazakhstan LLP, has received a penalty order from the Department of State Revenue, Bostandyk district, Almaty, Kazakhstan. Company Value Change %Change “This is to inform that our step-down wholly owned subsidiary “Dr Reddy’s Laboratories […]
Dr Reddy’s API facility in Hyderabad receives 7 USFDA observations following inspection – CNBC TV18
[ad_1] Dr Reddy’s Laboratories Ltd on Tuesday (November 19) announced the completion of a Good Manufacturing Practices (GMP) inspection by the United States Food and Drug Administration (USFDA) at its Active Pharmaceutical Ingredient (API) manufacturing facility (CTO-2) in Bollaram, Hyderabad. “This is to inform you that the United States Food & Drug Administration (USFDA) today […]